In addition, the results of the multivariate analyses revealed that PAX6 expression level independently predicted poor OS (hazard ratio: 2.542; 95% CI: 1.411–4.579, p = 0.002), as well as the clinical stage, invasion depth, tumor differentiation, and metastasis (Table S3). This evidence concerns the gene PAX6 and neoplasm.